Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
B.R.A.H.M.S GmbH currently manages 2 pending office actions within the Biotechnology & Pharmaceuticals technology area. These matters are distributed across 2 distinct examiners and 2 distinct art units. MISHRA, DEEPA is identified as the busiest examiner for this portfolio, as she is currently responsible for 1 pending office action. This distribution indicates that the company's current prosecution workload is split between different individuals and technological classifications.
The presence of 2 distinct examiners for the 2 pending office actions suggests that each matter is receiving a unique perspective from the patent office. Because these actions are also located in 2 distinct art units, the company is navigating multiple regulatory environments within the Biotechnology & Pharmaceuticals technology area. MISHRA, DEEPA handles 1 of these actions, representing a specific point of contact for the company. This level of variety in examiners and art units for the 2 pending office actions may require the company to manage different procedural expectations simultaneously across its active matters.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MISHRA, DEEPA | 1 | 28.9% | +35.5% |
| SAOUD, CHRISTINE J | 1 | 57.9% | +37.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18718852 | BIOMARKERS FOR THE PREDICTION OF PRETERM BIRTH | MISHRA, DEEPA | — |
| 17327271 | METHODS FOR DETECTING proADM IN A CRITICALLY ILL SUBJECT WHO HAS BEEN ADMITTED TO AN INTENSIVE CARE UNIT | SAOUD, CHRISTINE J | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18718852 | BIOMARKERS FOR THE PREDICTION OF PRETERM BIRTH | MISHRA, DEEPA | — |
| 17327271 | METHODS FOR DETECTING proADM IN A CRITICALLY ILL SUBJECT WHO HAS BEEN ADMITTED TO AN INTENSIVE CARE UNIT | SAOUD, CHRISTINE J | — |
| Art Unit | Apps |
|---|---|
| 1657 | 1 |
| 1645 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18718852 | BIOMARKERS FOR THE PREDICTION OF PRETERM BIRTH | MISHRA, DEEPA | 1657 | §101§103§112 | Non-Final OA | — | Pending | Jun 12, 2024 |
| 17327271 | METHODS FOR DETECTING proADM IN A CRITICALLY ILL SUBJECT WHO HAS BEEN ADMITTED TO AN INTENSIVE CARE UNIT | SAOUD, CHRISTINE J | 1645 | §101§112DP | Non-Final OA | — | Pending | May 21, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialB.R.A.H.M.S GmbH has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Deepa Mishra has the most, with 1 of B.R.A.H.M.S GmbH's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
